Latest Breaking News On - Association of molecular pathology - Page 14 : comparemela.com
COVID-19 tests again in short supply as infections soar, schools reopen
ksl.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksl.com Daily Mail and Mail on Sunday newspapers.
Exagen Appoints Ana Hooker to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Exagen Appoints Ana Hooker to Board of Directors
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Dr. John C. Spinosa Joins Murrieta Genomics as Chief Medical Officer
Share Article
Addition of noted pathologist to executive team provides insights into precision medicine and critical connections to the greater life science community.
Dr. John C. Spinosa MURRIETA, Calif. (PRWEB) February 02, 2021
Murrieta Genomics, the launch pad for genomic sequencing startups, has announced that John C. Spinosa, M.D., Ph.D., has joined the executive management team. He has also been appointed as Chief Medical Officer of SimplSEQ, Inc., a wholly owned subsidiary of Murrieta Genomics.
“We are fortunate to have attracted Dr. Spinosa to join us,” stated Jay Goth, CEO. “John’s background and experience with companies large and small will be critical to our future success helping genomic sequencing companies revolutionize the healthcare, agriculture and forensic industries. His reputation as a leading pathologist is well
Innovative breakthrough promises to diagnose DNA rearrangement mutations
Doctors are increasingly using genetic signatures to diagnose diseases and determine the best course of care, but using DNA sequencing and other techniques to detect genomic rearrangements remains costly or limited in capabilities.
However, an innovative breakthrough developed by researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Department of Physics promises to diagnose DNA rearrangement mutations at a fraction of the cost with improved accuracy.
Led by VCU physicist Jason Reed, Ph.D., the team developed a technique that combines a process called digital polymerase chain reaction (dPCR) with high-speed atomic force microscopy (HSAFM) to create an image with such nanoscale resolution that users can measure differences in the lengths of genes in a DNA sequence. These variations in gene length, known as polymorphisms, can be key to accurately diagnosing many forms of cancer and ne